Worldwide trends in lung cancer pathology
暂无分享,去创建一个
[1] F. Schmidt. Meta-Analysis , 2008 .
[2] R. Wilson,et al. Use of cigarette-smoking history to estimate the likelihood of mutations in epidermal growth factor receptor gene exons 19 and 21 in lung adenocarcinomas. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] J. Minna,et al. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. , 2006, Journal of the National Cancer Institute.
[4] C. Clavel,et al. Prevalence of human papillomaviruses in lung carcinomas: a study of 218 cases , 2005, Modern Pathology.
[5] F. Bray,et al. International lung cancer trends by histologic type: Male:Female differences diminishing and adenocarcinoma rates rising , 2005, International journal of cancer.
[6] W. Lam. Lung cancer in Asian women—the environment and genes * , 2005, Respirology.
[7] Laurie Kazan-Allen,et al. Asbestos and mesothelioma: worldwide trends. , 2005, Lung cancer.
[8] P. Hainaut,et al. TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers. , 2005, Cancer research.
[9] A. Sandler,et al. Redefining bronchioloalveolar carcinoma. , 2005, Seminars in oncology.
[10] Young Tae Kim,et al. Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] Takayuki Kosaka,et al. Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] M. Meyerson,et al. EGFR gene mutations: a call for global x global views of cancer. , 2005, Journal of the National Cancer Institute.
[13] A. Marchetti,et al. EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] T. Joshi,et al. Asbestos in Developing Countries: Magnitude of Risk and Its Practical Implications , 2005, International journal of occupational medicine and environmental health.
[15] Takayuki Kosaka,et al. Mutations of the Epidermal Growth Factor Receptor Gene in Lung Cancer , 2004, Cancer Research.
[16] D. Christiani,et al. Lung adenocarcinoma and human papillomavirus infection , 2004, Cancer.
[17] R. Wilson,et al. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[18] M. Chan-yeung,et al. Lung cancer epidemiology and risk factors in Asia and Africa. , 2004, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[19] S. Gabriel,et al. EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy , 2004, Science.
[20] Patricia L. Harris,et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. , 2004, The New England journal of medicine.
[21] Giovanni Parmigiani,et al. A Cross-Study Comparison of Gene Expression Studies for the Molecular Classification of Lung Cancer , 2004, Clinical Cancer Research.
[22] K. Shah,et al. Chapter 9: Role of mucosal human papillomavirus in nongenital cancers. , 2003, Journal of the National Cancer Institute. Monographs.
[23] J. Cerhan,et al. Adenocarcinoma of the lung is strongly associated with cigarette smoking: further evidence from a prospective study of women. , 2002, American journal of epidemiology.
[24] M. Kris,et al. Clinical pattern and pathologic stage but not histologic features predict outcome for bronchioloalveolar carcinoma. , 2002, The Annals of thoracic surgery.
[25] David E. Misek,et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma , 2002, Nature Medicine.
[26] David Sidransky,et al. Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. , 2002, Cancer research.
[27] W. Travis. Pathology of lung cancer. , 2002, Clinics in chest medicine.
[28] E. Lander,et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[29] D. Botstein,et al. Diversity of gene expression in adenocarcinoma of the lung , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[30] M. Olivier,et al. Lung tumor KRAS and TP53 mutations in nonsmokers reflect exposure to PAH-rich coal combustion emissions. , 2001, Cancer Research.
[31] G. Sheu,et al. The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. , 2001, Cancer research.
[32] S. Khuder,et al. Effect of cigarette smoking on major histological types of lung cancer: a meta-analysis. , 2001, Lung cancer.
[33] E. Lander,et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[34] D. Sidransky,et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. , 2000, Journal of the National Cancer Institute.
[35] Takashi Takahashi,et al. Risk Factors for Lung Cancer among Northern Thai Women: Epidemiological, Nutritional, Serological, and Bacteriological Surveys of Residents in High‐ and Low‐incidence Areas , 1999, Japanese journal of cancer research : Gann.
[36] K. Shroyer,et al. Detection of human papillomavirus in squamous cell carcinomas of the lung by polymerase chain reaction. , 1998, American journal of respiratory cell and molecular biology.
[37] Chih-Yi Chen,et al. Analysis of K-ras gene mutations in lung carcinomas: correlation with gender, histological subtypes, and clinical outcome , 1998, Journal of Cancer Research and Clinical Oncology.
[38] M. Djordjevic,et al. The changing cigarette. , 1997, Preventive medicine.
[39] S. Hecht,et al. The biological significance of tobacco-specific N-nitrosamines: smoking and adenocarcinoma of the lung. , 1996, Critical reviews in toxicology.
[40] E. Wynder,et al. The changing epidemiology of smoking and lung cancer histology. , 1995, Environmental health perspectives.
[41] C. Harris,et al. Mutagens from heated Chinese and U.S. cooking oils. , 1995, Journal of the National Cancer Institute.
[42] M. Lung,et al. Incidence of ras oncogene activation in lung carcinomas in Hong Kong , 1992, Cancer.
[43] A. Seaton,et al. Asbestos: scientific developments and implications for public policy. , 1990, Science.
[44] J. Chuang,et al. Lung cancer and indoor air pollution in Xuan Wei, China. , 1987, Science.
[45] A. Churg. Lung cancer cell type and asbestos exposure. , 1985, JAMA.
[46] J. Lubin,et al. Assessment of lung cancer risk factors by histologic category. , 1984, Journal of the National Cancer Institute.
[47] J H Holbrook,et al. The changing cigarette. , 1981, The Western journal of medicine.
[48] I J Selikoff,et al. ASBESTOS EXPOSURE, CIGARETTE SMOKING AND DEATH RATES * , 1979, Annals of the New York Academy of Sciences.